Articles & Newsletters | Minneapolis Heart Institute Foundation

Treatment for atrial fibrillation advancing rapidly

December 30, 2024

As Americans become older on average, the incidence of atrial fibrillation will continue to increase. The good news is that treatments for Afib are effective, tolerable, and brief.

Coronary Artery Disease

Bringing CT for PCI to the U.S.

MHIF's Center for Coronary Artery Disease hosted the CT for PCI Course 2.0

November 15, 2024

On October 24-25, MHIF's Center for Coronary Artery Disease hosted physicians from all over the world to learn about CT-guided PCI.

Navigating Atrial Fibrillation - Key Insights and Strategies for Better Heart Health

Heart Rhythm

Recapping Our Atrial Fibrillation Education Community Event

November 6, 2024

MHIF hosted a community education event on October 26, 2024, in St. Paul, MN, where nearly 100 attendees gained insights into atrial fibrillation from expert physician researchers.

Fundraising

Heart 360 Concert for Heart Research in the News

October 30, 2024

We’re celebrating the Minneapolis Heart Institute Foundation’s recent features on local news sharing details and excitement around Heart 360! Thank you to KSTP, WCCO, FOX 9 and KARE 11 for welcoming our leaders to speak about this important event and help share the importance of heart health and research!

Press Releases

First Enrollment in Research to Evaluate Evidence with SuperSaturated Oxygen (SSO2) Therapy in Reducing Heart Failure and Mortality

September 23, 2024

Minneapolis Heart Institute Foundation, an independent, world-class cardiovascular research and education organization announced today the first patient enrolled in the SuperSaturated oxygen Comprehensive Observational REgistry (SSCORE) Research Registry. The prospective study is designed to provide further evidence of the efficacy of SuperSaturated Oxygen (SSO₂) Therapy, manufactured by Zoll, to reduce heart failure and mortality in patients suffering from left anterior descending ST-elevation myocardial infarction (LAD STEMI) heart attacks, the most serious type of heart attack.

First U.S. Patient Randomized to CT-Guided PCI in P4 Research Trial Accelerating Innovation with Advanced Cardiovascular Imaging

August 29, 2024

Minneapolis Heart Institute Foundation® (MHIF) announced the first enrollments in the Precise Procedural and PCI Plan (P4) Research Trial evaluating the potential for advanced cardiovascular imaging to enhance patient care.

Minneapolis Heart Institute Foundation® Announces First Patient Enrolled in VISTA U.S. Study Evaluating Novel Tricuspid Valve Replacement Technology

April 11, 2024

Minneapolis Heart Institute Foundation® (MHIF) today announced the first enrollment in the VISTA U.S. early feasibility study offering a new transcatheter tricuspid valve technology for severe tricuspid valve regurgitation.

Sign Up For Our Newsletter

Stay up to date on MHIF news, events and the latest information on heart disease treatment and prevention.

News Articles